Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 52.74
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Oxygenta Pharmaceutical Ltd. engages in the development and manufacture of bulk drugs. It offers anti-ulcerative and anti-bacterial drugs. The company was founded on November 27, 1990 and is headquartered in Hyderabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks.
Data is available to registered users only
Buy
Sell